$PFE PFIZER ADVANCES BATTLE AGAINST COVID-19 ON MULTIPLE FRONTS
Thursday, April 09, 2020 - 07:50am
1. Anti-viral compounds show activity against SARS-CoV-2 in preclinical screening 2. Pfizer and BioNTech enter into collaboration agreement to co-develop potential COVID-19 vaccine 3. Company shares additional data and analysis of azithromycin 4. Launch of two new studies to provide insights on the interaction between S. pneumoniae and SARS-CoV-2 5. Pfizer explores studies of JAK inhibitor tofacitinib in patients with COVID-19-related pneumonia